LEADER 01067nam--2200361---450-
001 990000361450203316
035   $a0036145
035   $aUSA010036145
035   $a(ALEPH)000036145USA01
035   $a0036145
100   $a20010315d1972----km-y0itay0103----ba
101   $aeng
102   $aUS
105   $a||||||||001yy
200 1 $aComputer organization and microprogramming$fYaohan Chu
210   $aEnglewood Cliffs$cPrentice Hall$dc1972
215   $aXX, 533 p.$cill., tab.$d23 cm
410   $12001
461  1$1001-------$12001
610 0 $aElaboratori elettronici digitali$xFunzioni
610 0 $aMicroprogrammazione
676   $a001.64044
700  1$aCHU,$bYaohan$0104626
801  0$aIT$bsalbc$gISBD
912   $a990000361450203316
951   $a001.640 44 CHU$b9862$c001.64044$d00105631
959   $aBK
969   $aSCI
979   $aPATTY$b90$c20010315$lUSA01$h1450
979   $c20020403$lUSA01$h1644
979   $aPATRY$b90$c20040406$lUSA01$h1625
996   $aComputer organization and microprogramming$9876820
997   $aUNISA

LEADER 01355nam--2200361---450-
001 990003574950203316
005 20111012114717.0
010   $a978-92-9168-457-1
035   $a000357495
035   $aUSA01000357495
035   $a(ALEPH)000357495USA01
035   $a000357495
100   $a20111012d2011----km-y0itay50------ba
101   $aeng
102   $aLU
105   $a||||||||001yy
200 1 $aReport on the risk assessment of mephedrone in the framework of the Council decision on new psychoactive substances$fEuropean monitoring centre for drugs and drug addiction
210   $aLuxembourg$cPublications office of the European Union$d2011
215   $a193 p.$cill.$d21 cm
225 2 $aEMCDDA Risk assessments$v9
410  0$12001$aEMCDDA Risk assessments
606 0 $aDroghe$xConsumo$yPaesi dell'Unione europea$2BNCF
676   $a362.29094
699   $a16.04$bLotta contro la droga
710 02$aOSSERVATORIO EUROPEO DELLE DROGHE E DELLE TOSSICODIPENDENZE$0547105
801  0$aIT$bsalbc$gISBD
912   $a990003574950203316
951   $aCDE 16.04 (XLV)$bCDE 2745$cCDE 16.04$d00185039
959   $aBK
969   $aCDE
979   $aMARIAS$b90$c20111012$lUSA01$h1147
996   $aReport on the risk assessment of mephedrone in the framework of the Council decision on new psychoactive substances$91116064
997   $aUNISA